A new target for the treatment of trigeminal neuralgia with botulinum toxin type A
Chuanjie Wu(Capital Medical University), Yajun Lian(First Affiliated Hospital of Zhengzhou University), Lu Zhang(Zhujiang Hospital), Haifeng Zhang(Jiangsu Province Hospital), Nanchang Xie(First Affiliated Hospital of Zhengzhou University), Hongbo Liu(First Affiliated Hospital of Zhengzhou University)
Cited by 9
Related Papers
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial
|Cephalalgia|2012|217
Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy
|Stroke|2017|174
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
|The Journal of Headache and Pain|2014|170
Safety, feasibility, and potential efficacy of intraarterial selective cooling infusion for stroke patients treated with mechanical thrombectomy
|Journal of Cerebral Blood Flow & Metabolism|2018|118